With opening of China centers, (as company has developed a Sirtex website for Chinese population), the Singapore plant will be able to supply Sir Spheres on a timely basis to the Chinese and Indian and Asian populations. Seems as if growth could exceed 100% in this region which is similar to European growth. US growth will get another surge as Sirtex has been making the US Journal of Oncology publications on a very positive basis for its clinical trials for Sir Spheres being used in many more indications.
With opening of China centers, (as company has developed a...
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.5¢ | $1.602K | 9.154K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 3847679 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 2509481 | 36 |
View Market Depth
| Last trade - 15.19pm 23/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |